Cargando…

The Dexamethasone-CRH Stimulation Test: A Single-Center Experience

Background: The diagnostic value of adding a Corticotropin Releasing Hormone (CRH) Stimulation Test to the 2-day Low Dose Dexamethasone Suppression Test (Dex-CRH Test) has been debated in the literature. We hypothesized that adding CRH to LDDST would provide additional case detection in patients sus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wehbeh, Leen, Alwahab, Ula Abed, Mikhael, Alexandra, Dobri, Georgiana, Kennedy, Laurence, Hamrahian, Amir Hekmat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Adrenal
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090089/ http://dx.doi.org/10.1210/jendso/bvab048.194

Ejemplares similares

A Re-Examination of the oCRH Stimulation Test for the Diagnosis of Ectopic ACTH Secretion
por: Newman, Andrew Joseph, et al.
Publicado: (2021)

ODP036 Cortisol Values During the Standard-Dose Cosyntropin Stimulation Test: Personal Experience with Elecsys Cortisol II Assay
por: Hamrahian, Amir, et al.
Publicado: (2022)

SAT-361 Rapid Glucocorticoid Regulation of Adrenoreceptor Trafficking Desensitizes CRH Neurons to Noradrenergic Activation
por: Weiss, Grant, et al.
Publicado: (2019)

SAT-372 Correlation of Serum Dexamethasone and Cortisol Concentrations Post Dexamethasone 1 Mg in the Overnight Dexamethasone Suppression Test in Patients with Unilateral and Bilateral Adrenal Incidentalomas
por: Naseem, Asma, et al.
Publicado: (2019)

MON-187 Prevalence and Assessment of Overnight Dexamethasone Suppression Tests for Screening Endogenous Hypercortisolism When Serum Dexamethasone Is Below Threshold
por: Farinelli, Denise Genaro, et al.
Publicado: (2020)

MON-169 Diagnostic Utility of Free Cortisol in Dexamethasone Suppression Test. A Prospective Study in Healthy Subjects
por: Athimulam, Shobana, et al.
Publicado: (2020)

The Combined Dexamethasone/CRH Test (DEX/CRH Test) and Prediction of Acute Treatment Response in Major Depression
por: Schüle, Cornelius, et al.
Publicado: (2009)

RF09 | PSAT83 Diagnosis of Adrenal Insufficiency Based on Peak Stimulated Cortisol Levels Between 14 and 18 mcg/dL on High Dose Cosyntropin Stimulation Testing
por: Martirossian, Alexandra, et al.
Publicado: (2022)

SAT-371 Correlation of Midnight and Post Dexamethasone Salivary Cortisone and Cortisol with Post Dexamethasone Serum Cortisol Concentrations In Patients with Unilateral and Bilateral Adrenal Incidentalomas
por: Naseem, Asma, et al.
Publicado: (2019)

Acute Transcriptional Effects of Dexamethasone on Mouse Adrenal Gland Transcriptome
por: Zheng, Huifei Sophia, et al.
Publicado: (2021)

SAT-369 Proposal of Optimal Cutoff value for Serum Cortisol after an Overnight 1-mg Dexamethasone Suppression Test - Results from Multicenter Collaborative Research in Japan.
por: Tanabe, Makito, et al.
Publicado: (2019)

SAT-376 Dynamic Modeling of the 1 mg Overnight Dexamethasone Suppression Test: Sources of Variability and Strategies to Improve Diagnostic Accuracy for Detection of Autonomous Cortisol Secretion in Adrenal Adenoma Patients
por: Kambhatla, Akshaya, et al.
Publicado: (2019)

ODP047 Intramuscular ACTH stimulation test in a patient with liver disease
por: Khurram, Daniyeh, et al.
Publicado: (2022)

SUN-378 Adrenocortical Carcinoma Diagnosed During Evaluation of an Incidentally Discovered Adrenal Mass
por: Fatima, Nishat, et al.
Publicado: (2019)

SAT-166 Advantage and Trustworthy of Cortisol and Dexamethasone Evaluation in Different Biological Matrices in Patients with Adrenal Masses
por: Lionetto, Luana, et al.
Publicado: (2020)

MON-165 Utility of Salivary Cortisol After 1 Mg Oral Dexamethasone in the Evaluation of Incidental Adrenal Tumors
por: Arregger, Alejandro L, et al.
Publicado: (2020)

MON-156 Efficacy and Safety of Prenatal Dexamethasone Treatment in Offspring at Risk for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Xu, Lizhen, et al.
Publicado: (2020)

MON-276 Post-Surgical Metabolic Outcomes in Adult-Onset Craniopharyngioma: A Single Pituitary Center Experience
por: Duan, Daisy, et al.
Publicado: (2020)

SUN-371 Successful Induction of Fertility with Low-Dose Dexamethasone in a Patient with Congenital Adrenal Hyperplasia and Testicular Adrenal Rest Tumor
por: Jha, Smita, et al.
Publicado: (2019)

MON-LB065 A Norepinephrine-Only Secreting Pheochromocytoma in the Absence of an Identifiable Genetic Defect
por: Kumar, Monisha Priyadarshini, et al.
Publicado: (2019)

SAT-164 Pattern and Spectrum of Adrenal Disorders Seen Among Adults in Southern Iraq. A Tertiary Center Experiences
por: Mansour, Abbas Ali, et al.
Publicado: (2020)

What Cut-off Value of 17-Hydroxyprogesterone Should Be an Indication to Perform a 250 µg Cosyntropin Stimulation Test When NCCAH Is Suspected? - a Retrospective Study
por: Domagala, Bartosz, et al.
Publicado: (2021)

FRI172 Assessment Of Plasma Dexamethasone Levels After 1-mg Dexamethasone Suppression Test In Adults With Obesity
por: Paopongpaiboon, Pimonrat, et al.
Publicado: (2023)

Outcome of CRH stimulation test and overnight 8 mg dexamethasone suppression test in 469 patients with ACTH-dependent Cushing’s syndrome
por: Detomas, Mario, et al.
Publicado: (2022)

SAT-390 New Cortisol Threshold for Diagnosis of Adrenal Insufficiency After Cosyntropin Stimulation Testing Using the Elecsys Cortisol II, Access Cortisol, and LC-MS/MS Assays
por: Javorsky, Bradley, et al.
Publicado: (2019)

Nephrotic Syndrome Following Resection of an Adrenal Incidentaloma:A Case Report
por: Batool, Maria, et al.
Publicado: (2021)

LBSAT56 Adrenal And Juxta-adrenal Schwannomas: A Single Center Study
por: Rolak, Stacey, et al.
Publicado: (2022)

MON-198 Cosyntropin Stimulation on Adrenal Venous Sampling Obscure Surgically Curable Primary Aldosteronism
por: Kobayashi, Hiroki, et al.
Publicado: (2020)

FRI171 Can 11-Dehydrodexamethasone Improve The Salivary Dexamethasone Suppression Test?
por: Marshall, David, et al.
Publicado: (2023)

OR29-4 Pregnancy Outcomes in Women with Pheochromocytoma and Paraganglioma: An International Multi-Center Study
por: Bancos, Irina, et al.
Publicado: (2019)

SAT-180 Adrenocortical Carcinoma - A Tertiary Center’s Recent 5-Year Experience
por: Ehrenwald, Michal, et al.
Publicado: (2020)

MON-221 Seated Saline Suppression Testing Is Comparable to Captopril Challenge Test for the Diagnosis of Primary Aldosteronism: A Prospective Study
por: Hu, Jinbo, et al.
Publicado: (2020)

PSUN18 Comprehensive Evaluation of Adrenal Cortical Cancer: Single-center 22-year Experience
por: Zakhour, Joud, et al.
Publicado: (2022)

PSAT008 Pheochromocytoma Management: Considerations for Cardiac Stress Testing
por: Gandhi, Shriya, et al.
Publicado: (2022)

PSUN25 Adrenal Incidentaloma: Is Interval Hormone Testing Warranted?
por: Wachira, Lianne, et al.
Publicado: (2022)

OR12-2 Inhibition of Basal and ACTH-stimulated Cortisol Secretion in Humans Using an Oral Nonpeptide ACTH Antagonist (CRN04894)
por: Betz, Stephen, et al.
Publicado: (2022)

SAT-171 Adrenocortical Carcinoma in Thailand: A 10-Year Retrospective Review in a Single Tertiary Center
por: Gomutput, Patrawon, et al.
Publicado: (2020)

MON-206 Diagnosis of Non-Functional Masses in Adrenal Gland Topography - Experience of a Tertiary Health Center
por: Brondani, Vânia Balderrama, et al.
Publicado: (2020)

MON-196 A Single-Center Experience of Patients with Metastatic Pheochromocytoma/Paraganglioma Treated with (177)Lu-DOTATATE
por: Roslyakova, Anna, et al.
Publicado: (2020)

Changes in Clinical Presentation and Perioperative Management of Pheochromocytomas and Paragangliomas: A Four-Decade Experience in a Academic Center
por: Uslar, Thomas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qv0cjva3tvu9cpg40erbmpgrav